Stock Analysts

SunEdison & Adani to Build Solar Plant in Gujarat, India

Solar technology company SunEdison Inc. ( SUNE ) has reportedly entered into a strategic alliance with Indian conglomerate Adani Enterprises, which will expand its base in India. Under the joint venture agreement, the companies will put up approximately $4 billion to develop solar photovoltaic projects in Gujarat, India. […]

Stock Analysts

Dover (DOV) Launches a New 15M Share Buyback Program

The Board of Dover Corporation ( DOV ) sanctioned a new stock repurchase program, replacing the prior authorization of 10 million shares, which allows the company to buy back up to 15 million shares over the next three years. The new share repurchase authorization is in sync with the company’s long-standing history of dividend increases and share repurchases. Dover intends to fund the new buyback through cash on hand, proceeds from divestitures and free cash flow […]

Stock Analysts

Regeneron/Sanofi Seek PCSK9 Drug Praluent Approval in EU

Regeneron Pharmaceuticals, Inc. ( REGN ) and Sanofi ( SNY ) announced that the Marketing Authorisation Application for their PCSK9 (proprotein convertase subtilisin/kexin type 9) antibody, Praluent, has been accepted by the European Medicines Agency. The companies are looking to get the candidate approved for the treatment of patients suffering from hypercholesterolemia […]

Stock Analysts

Cisco (CSCO), Proximus Renew Strategic Alliance at CES

The 2015 Consumer Electronics Show (CES) saw Cisco Systems Inc. ( CSCO ) renew its partnership with Proximus, a Belgian telecom and IT service provider. This expanded partnership throws light on Cisco’s efforts to move beyond selling networking gear and become an enterprise IT solutions provider, with competency ranging from software-defined data centers to the Internet of things […]

Stock Analysts

Emergent BioSolutions Provides Preliminary 2014 Results

Emergent BioSolutions ( EBS ) announced preliminary results for 2014 and provided an outlook for 2015. The company expects 2014 total revenue in the range of $445 million – $450 million, narrower than the previously guided range of $440 million – $460 million but up 43% at the midpoint from the year-ago period. The Zacks Consensus Estimate for 2014 revenues is $445 million, towards the lower end of the company’s projected range […]

Stock Analysts

Shire to Acquire NPS Pharmaceuticals for $5.2B

In a move to further strengthen its rare disease portfolio, Shire plc ( SHPG ) announced that it will acquire NPS Pharmaceuticals, Inc ( NPSP ), a biopharmaceutical company focused on rare diseases, for $46.00 per share or approximately $5.2 billion in total. The offered price of $46.00 per share represents a 51% premium to NPS Pharma's share price of $30.47 on Dec 16, 2014. The closing of the transaction is expected in the first quarter of 2015. […]

Stock Analysts

Steven Madden Beats Preliminary Q4 Sales, Cuts FY View

Shoe and fashion accessories retailer Steven Madden Ltd. ’s ( SHOO ) shares slipped 2.4% in the trading session on Jan 9, after the Long Island City, NY-based company reported soft preliminary sales results for the fourth quarter fiscal 2014 on the same day. Net sales in the fourth quarter remained flat with the year-ago quarter at $342.6 million as year-over-year gain in the retail division was offset by a decline in the wholesale division. […]